ContactDr Philip Wong, Chief Executive Officer & Chief Technical Officer
Ms Pan Yumei, Manager & Marketing Head
Email:
ym_pan@innoheart.com
Nature of Business
GLP-CERTIFIED MEDTECH PRECLINICAL CONTRACT RESEARCH ORGANISATION (CRO)
Innoheart was set up in 2006 as a pre-clinical contract research organisation. It is the first dedicated facility of its kind in the Asia Pacific region providing GLP-certified in-life studies for biomedical devices, biologics and other medical implants.
Services & Capabilities
Innoheart's main focus is medical device implants, such as stents. However, its one-stop facility allows a diverse array of in-life study protocols to be carried out, including cell therapy, spinal/orthopedic, dental and eye studies. Besides offering study planning and project management services, Innoheart also conducts hands-on training courses in complex cardiovascular, endovasular, and minimally-invasive surgical procedures such as laparoscopic or endoscopic surgery.
Innoheart's 12,000 sq foot facility is fully equipped with state-of-the-art imaging, surgical and histology facilities, enabling it to offer a comprehensive suite of services for complex in-life study protocols. The facility has holding areas for both small and large experimental models.